Table 3 Signal functions provided by health facilities in the study area
Signal function | Baseline | Endline | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
(n = 74) | (n = 69) | |||||||||||
FWC | MCWC | UHC | Dist. Hosp. | Private | Total | FWC | MCWC | UHC | Dist. Hosp. | Private | Total | |
N = 30 | N = 1 | N = 12 | N = 1 | N = 30 | N = 74 | N = 29 | N = 1 | N = 12 | N = 1 | N = 26 | N = 69 | |
Administration of antibiotic | 0 | 1 | 7 | 1 | 21 | 30 | 0 | 1 | 7 | 1 | 20 | 29 |
Administration of intravenous fluid | 0 | 1 | 7 | 1 | 22 | 31 | 1 | 1 | 7 | 1 | 19 | 29 |
Administration of uterotonics | 0 | 1 | 7 | 1 | 23 | 32 | 0 | 1 | 7 | 1 | 20 | 29 |
Removal of retained products (≤12 weeks) | 0 | 0 | 8 | 1 | 18 | 27 | 0 | 0 | 7 | 1 | 18 | 26 |
Post-procedure contraception | 23 | 1 | 4 | 0 | 4 | 32 | 24 | 1 | 5 | 0 | 6 | 36 |
MR (≤10 weeks) and/or safe, legal abortion (≤12 weeks) | 28 | 1 | 4 | 0 | 6 | 39 | 25 | 1 | 5 | 0 | 6 | 37 |
Basic SMRAC facilities (20 recommended: 4 per 500,000 population) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Removal of retained products (>12 weeks) | 0 | 0 | 6 | 1 | 13 | 20 | 0 | 0 | 6 | 1 | 15 | 22 |
Blood transfusion | 0 | 0 | 4 | 1 | 18 | 23 | 0 | 0 | 4 | 1 | 19 | 24 |
Laparotomy | 0 | 0 | 2 | 1 | 18 | 21 | 0 | 0 | 2 | 1 | 16 | 19 |
Safe, legal abortion (>12 weeks) | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 2 | 1 | 1 | 4 |
Comprehensive SMRAC facilities (5 recommended:1 per 500,000 population) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |